Antidepressant adverse effects in the elderly: Analysis of spontaneous reports in France;Effets indésirables des antidépresseurs chez le sujet âgé: Analyse des notifications en France

Therapie

Volumn 60, Issue 1, 2005, Pages 61-65

  Daurel Receveur, Mathilde ^a   Miremont Salamé, Ghada ^a,c   Fourrier, Annie ^a   Auriche, Pascal ^b   Moore, Nicholas ^a   Bégaud, Bernard ^a   Haramburu, Françoise ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b AFSSAPS   (France)

^c HÔPITAL PELLEGRIN   (France)

Author keywords

Adverse effects; Antidepressants; Elderly; Pharmacovigilance

Indexed keywords

AMITRIPTYLINE; AMOXAPINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOSULEPIN; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; IPRONIAZID; MAPROTILINE; MIANSERIN; MILNACIPRAN; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIANEPTINE; TOLOXATONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; VENLAFAXINE; VILOXAZINE;

AGED; AGITATION; AGRANULOCYTOSIS; ANGIONEUROTIC EDEMA; ARTICLE; ATRIOVENTRICULAR BLOCK; BLOOD TOXICITY; BONE MARROW APLASIA; CARDIOTOXICITY; CONFUSION; CONVULSION; DRUG MARKETING; DRUG SURVEILLANCE PROGRAM; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FRANCE; GERIATRIC CARE; HALLUCINATION; HUMAN; HYPONATREMIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEPHROTOXICITY; NEUROTOXICITY; ORTHOSTATIC HYPOTENSION; PRESCRIPTION; PRIORITY JOURNAL; THROMBOCYTOPENIA; TORSADE DES POINTES; TREMOR;

EID: 16344394060     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie:2005008     Document Type: Article

References (24)

1. Le Pape A, Lecomte T. Prévalence et prise en charge médicale de la dépression en 1996-1997. Paris: CREDES (Centre de Recherche et Documentation en Economie de la Santé), septembre 1999, n° 21
2. NIH consensus conference. Diagnosis and treatment of depression in late life. JAMA 1992; 268: 1018-24
3. Fremont P. L'utilisation des psychotropes chez le sujet âgé: trop ou trop peu? Dossier: médicaments et sujets âgés. Presse Med 1999; 28: 1794-9
4. Barbier D. Dossier: la dépression du sujet âgé. Presse Med 2001; 30: 337-55
5. Fourrier A, Letenneur L, Dartigues J, et al. Consommation médicamenteuse chez le sujet âgé vivant à domicile et en institution à partir de la cohorte Paquid: importance de la polymédication et utilisation des psychotropes. Revue Geriatrie 1996; 21: 473-82
6. Rouillon F, Blachier C, Dreyfus JP, et al. Etude pharmacoé pidémiologique de la consommation des antidépresseurs en population générale. Encephale 1996; Spec No 1: 39-48
7. Tourigny-Rivard MF. Pharmacotherapy of affective disorders in old age. Can J Psychiatry 1997; 42 Suppl. 1: 10S-8S
8. Dalery J, Aubin V. Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence. Encephale 2001; 27: 71-81
9. WHO-ART (World Health Organization Adverse Reaction Terminology). Uppsala: WHO Collaborating Centre For International Drug Monitoring, 2002
10. Moride Y, Haramburu F, Requejo AA, et al. Under-reporting of adverse drug reactions in general practice. Br J Clin Pharmacol 1997; 43: 177-81
11. Etude de la prescription et de la consommation des antidépresseurs en ambulatoire. Observatoire national des prescriptions et consommations des médicaments dans les secteurs ambulatoires et hospitaliers - Agence du médicament; juillet 1998 [online]. Available from URL: http://agmed.sante.gouv.fr/pdf/5/5014.pdf [Accessed 2004 Dec 3]
12. Montano CB. Primary care issues related to the treatment of depression in elderly patients. J Clin Psychiatr 1999; 60: 45-51
13. Anonyme. Fiche gériatrie. Antidépresseurs. Dossiers du CNIMH 1990; XI, n° 2: 103-113
14. Baldwin RC, Andersen D, Black S, et al. Guideline for the management of late-life depression in primary care. Int J Geriatr Pshychiatry 2003; 18: 829-38
15. Bourin M. Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review. Hum Psychopharmacol 2003; 18: 185-90
16. Bourin M, David DJP, Jolliet P, et al. Mécanisme d'action des antidépresseurs et perspectives thérapeutiques. Therapie 2002; 57: 385-96
17. Spigset O. Adverse reactions of selective serotonin reuptake inhibitors. Drug Saf 1999; 20: 277-87
18. Gareri P, Stilo G, Bevacqua I, et al. Antidepressant drugs in the elderly. Gen Pharmacol 1998; 30: 465-75
19. Emeriau JP, Fourrier A, Dartigues, et al. Prescription médicamenteuse chez les personnes âgées. Bull Acad Natl Med 1998; 182: 1419-28
20. Gareri P, Falconi U, De Fazio P. et al. Conventional and new antidepressant in the elderly. Prog Neurobiol 2000; 61: 353-96
21. Kehoe WA. Factors affecting the use and selection of antidepressants in the elderly. Expert Rev Neurotherapeutics 2002; 2: 35-43
22. Anonyme. Interactions médicamenteuses avec les antidépresseurs inhibiteurs de la recapture de la sérotonine. Prescrire 2000; 207: 439-46
23. Lawlor DA, Patel R, Ebrahim S. Association between falls in elderly women and chronic diseases and drug use: cross sectional study. BMJ 2003; 327: 712-7
24. Leipzig RM. Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis. I: psychotropic drugs. Am J Geriatr Soc 1999; 47: 30-9